These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16674103)

  • 1. Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype.
    Keshamouni VG; Michailidis G; Grasso CS; Anthwal S; Strahler JR; Walker A; Arenberg DA; Reddy RC; Akulapalli S; Thannickal VJ; Standiford TJ; Andrews PC; Omenn GS
    J Proteome Res; 2006 May; 5(5):1143-54. PubMed ID: 16674103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells.
    Saito RA; Watabe T; Horiguchi K; Kohyama T; Saitoh M; Nagase T; Miyazono K
    Cancer Res; 2009 Apr; 69(7):2783-91. PubMed ID: 19293183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geraniin inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses A549 lung cancer migration, invasion and anoikis resistance.
    Ko H
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3529-34. PubMed ID: 26169124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal quantitative proteomics by iTRAQ 2D-LC-MS/MS and corresponding mRNA expression analysis identify post-transcriptional modulation of actin-cytoskeleton regulators during TGF-beta-Induced epithelial-mesenchymal transition.
    Keshamouni VG; Jagtap P; Michailidis G; Strahler JR; Kuick R; Reka AK; Papoulias P; Krishnapuram R; Srirangam A; Standiford TJ; Andrews PC; Omenn GS
    J Proteome Res; 2009 Jan; 8(1):35-47. PubMed ID: 19118450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics profiling of Madin-Darby canine kidney plasma membranes reveals Wnt-5a involvement during oncogenic H-Ras/TGF-beta-mediated epithelial-mesenchymal transition.
    Chen YS; Mathias RA; Mathivanan S; Kapp EA; Moritz RL; Zhu HJ; Simpson RJ
    Mol Cell Proteomics; 2011 Feb; 10(2):M110.001131. PubMed ID: 20511395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dioscin suppresses TGF-β1-induced epithelial-mesenchymal transition and suppresses A549 lung cancer migration and invasion.
    Lim WC; Kim H; Kim YJ; Choi KC; Lee IH; Lee KH; Kim MK; Ko H
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3342-3348. PubMed ID: 28610976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sanguiin H6 suppresses TGF-β induction of the epithelial-mesenchymal transition and inhibits migration and invasion in A549 lung cancer.
    Ko H; Jeon H; Lee D; Choi HK; Kang KS; Choi KC
    Bioorg Med Chem Lett; 2015 Dec; 25(23):5508-13. PubMed ID: 26508552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
    Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H
    Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation.
    Ellenrieder V; Hendler SF; Boeck W; Seufferlein T; Menke A; Ruhland C; Adler G; Gress TM
    Cancer Res; 2001 May; 61(10):4222-8. PubMed ID: 11358848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
    Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
    Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative Analysis of Differential Proteome Expression in Epithelial-to-Mesenchymal Transition of Bladder Epithelial Cells Using SILAC Method.
    Yang G; Lu W; Yu D; Sun C; Guo J; Li Z; Guan F
    Molecules; 2016 Jan; 21(1):84. PubMed ID: 26784156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-β-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinoma.
    Malfettone A; Soukupova J; Bertran E; Crosas-Molist E; Lastra R; Fernando J; Koudelkova P; Rani B; Fabra Á; Serrano T; Ramos E; Mikulits W; Giannelli G; Fabregat I
    Cancer Lett; 2017 Apr; 392():39-50. PubMed ID: 28161507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control.
    Grassi ML; Palma CS; Thomé CH; Lanfredi GP; Poersch A; Faça VM
    J Proteomics; 2017 Jan; 151():2-11. PubMed ID: 27394697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptome profiling of a TGF-beta-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies.
    Lenferink AE; Cantin C; Nantel A; Wang E; Durocher Y; Banville M; Paul-Roc B; Marcil A; Wilson MR; O'Connor-McCourt MD
    Oncogene; 2010 Feb; 29(6):831-44. PubMed ID: 19935703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphoproteomic study of human tubular epithelial cell in response to transforming growth factor-beta-1-induced epithelial-to-mesenchymal transition.
    Chen YX; Li Y; Wang WM; Zhang W; Chen XN; Xie YY; Lu J; Huang QH; Chen N
    Am J Nephrol; 2010; 31(1):24-35. PubMed ID: 19864886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arenobufagin, isolated from toad venom, inhibited epithelial-to-mesenchymal transition and suppressed migration and invasion of lung cancer cells via targeting IKKβ/NFκB signal cascade.
    Zhao J; Zhang Q; Zou G; Gao G; Yue Q
    J Ethnopharmacol; 2020 Mar; 250():112492. PubMed ID: 31866511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TMEPAI regulates EMT in lung cancer cells by modulating the ROS and IRS-1 signaling pathways.
    Hu Y; He K; Wang D; Yuan X; Liu Y; Ji H; Song J
    Carcinogenesis; 2013 Aug; 34(8):1764-72. PubMed ID: 23615405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ezrin is required for epithelial-mesenchymal transition induced by TGF-β1 in A549 cells.
    Chen MJ; Gao XJ; Xu LN; Liu TF; Liu XH; Liu LX
    Int J Oncol; 2014 Oct; 45(4):1515-22. PubMed ID: 25051016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
    He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
    J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celecoxib and sulindac inhibit TGF-β1-induced epithelial-mesenchymal transition and suppress lung cancer migration and invasion via downregulation of sirtuin 1.
    Cha BK; Kim YS; Hwang KE; Cho KH; Oh SH; Kim BR; Jun HY; Yoon KH; Jeong ET; Kim HR
    Oncotarget; 2016 Aug; 7(35):57213-57227. PubMed ID: 27528025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.